Medicines for psychotic conditions

Antipsychotic agents

This page about medicines for psychotic conditions automatically lists related information collected from other pages of our website.

The Medicines for psychotic conditions subcategory of medicines is also known as antipsychotics and antipsychotic agents.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Information for health professionals  

Antipsychotic monitoring tool

Systematic monitoring and prompt management of adverse drug reactions can assist in patients’ adherence to antipsychotics and optimising the physical health of patients. This antipsychotic monitoring tool lists recommended monitoring intervals and what you need to check for in patients taking antipsychotic medicines long term.

 

Comparative information on antipsychotic medicines

This information sheet shows comparative information on common oral antipsychotic medicines including indications, doses, and their common and serious adverse effects.

Related information - medicines for psychotic conditions

Audience:
       

(Media release)
01 Jul 2016 The latest issue of Australian Prescriber raises awareness of the challenges of dealing with people seeking prescription drugs.
(Medicine)
31 May 2016 View our tables of medicines that influence blood sugar (glucose) levels here. Some medicines can interact with your diabetes medicines, be aware of the adverse affects and know the active ingredients.
For health professionals (Health professional publication)
30 Sep 2014 Children and adolescents are known to be more vulnerable to antipsychotic-associated adverse effects such as obesity. With the use of these medicines on the rise, being familiar with monitoring and managing adverse effects in this population is vital.
For health professionals (CPD activity)
23 May 2014 Determine the appropriateness of the use of antipsychotic medicines for managing behavioural and psychological symptoms of dementia within your aged care facility. Identify opportunities for improving quality use of these medicines, and act on them.
(Media release)
14 Apr 2014 NPS MedicineWise has welcomed the recommendations of the recently released Senate Committee report on the care of Australians living with dementia and is encouraging residential aged care facilities to tackle the overuse of antipsychotics medicines in people with behavioural or psychological problems associated with dementia
(Media release)
14 Apr 2014 Following the release of a Senate Committee report on the care of Australians living with dementia, NPS MedicineWise is urging the families of people with dementia to play a part in monitoring treatment of their loved one, especially if the person with dementia has been prescribed antipsychotics to manage some of the behavioural or psychological problems associated with the condition.
For health professionals (e-newsletter for health professionals)
19 Sep 2013 Rapid HIV testing: better or just faster? | • Antipsychotic overuse in dementia: is there a problem? | Does finasteride prevent or promote prostate cancer? | Treat with statins according to absolute cardiovascular disease risk | Changes to pack size for paracetamol | Fast five: Medicines in older people
For health professionals (Health professional publication)
12 Sep 2013 Behaviourial and psychological problems occur in almost all people with dementia. They can be very distressing to patients and carers, but is antipsychotic use appropriate? Research has demonstrated that many dementia patients may not be receiving best-practice care.
For health professionals (Topic)
30 Aug 2013 Tools and resources to help manage medicine use in older, elderly patients.
(Media release)
12 Aug 2013 NPS MedicineWise and Webstercare have collaborated for the first time on a project to assist in the review of antipsychotic medicine use in residential aged care facilities.

Active ingredients used in medicines for psychotic conditions